Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 59.50B | 53.97B | 45.67B | 38.90B | 35.96B | 35.14B |
Gross Profit | 50.71B | 47.54B | 40.10B | 34.44B | 32.00B | 31.09B |
EBITDA | 10.23B | 13.27B | 10.18B | 8.80B | 7.66B | 6.96B |
Net Income | 6.70B | 7.23B | 6.41B | 5.41B | 4.80B | 4.76B |
Balance Sheet | ||||||
Total Assets | 72.02B | 72.47B | 65.10B | 56.59B | 49.44B | 51.00B |
Cash, Cash Equivalents and Short-Term Investments | 16.30B | 18.24B | 16.96B | 14.64B | 10.54B | 11.09B |
Total Debt | 7.39B | 6.43B | 8.33B | 10.37B | 13.52B | 18.00B |
Total Liabilities | 29.33B | 28.19B | 26.68B | 26.59B | 26.79B | 31.60B |
Stockholders Equity | 42.69B | 44.28B | 38.42B | 29.99B | 22.66B | 19.40B |
Cash Flow | ||||||
Free Cash Flow | 3.09B | 6.06B | 5.59B | 7.81B | 4.73B | 3.99B |
Operating Cash Flow | 3.19B | 9.77B | 8.50B | 9.82B | 6.77B | 5.59B |
Investing Cash Flow | -942.50M | -3.74B | -3.76B | -2.08B | -1.78B | -2.13B |
Financing Cash Flow | -3.31B | -5.02B | -3.04B | -3.99B | -5.22B | -3.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥282.11B | 45.49 | 0.37% | 29.09% | 87.01% | ||
75 Outperform | ¥46.57B | 57.88 | 1.55% | 18.96% | -13.13% | ||
73 Outperform | ¥138.65B | 19.50 | 1.81% | 10.66% | 0.41% | ||
72 Outperform | ¥21.10B | 20.75 | 1.45% | 13.39% | 12.00% | ||
71 Outperform | €104.10B | 45.76 | 12.05% | ― | 42.90% | -16.04% | |
65 Neutral | ¥341.96B | 11.05 | -0.16% | 2.40% | 9.83% | -10.32% | |
43 Neutral | ¥20.59B | 4,465.71 | 1.32% | -0.58% | -260.22% |